ICMR and Zydus Lifesciences initiate second phase proof-of-concept trial for Desidustat in patients with sickle cell disease
A view of the Indian Council of Medical Research (ICMR) in New Delhi. File | Photo Credit: The Hindu The Indian Council of Medical Research (ICMR) has formalised a Memorandum of Agreement with Zydus Lifesciences Limited to initiate phase-2 clinical trials for the drug Desidustat in patients with sickle cell disease. “Desidustat was invented in…